IL6 and cervical carcinoma: Strikingly, RES can downregulate the expression of IL‐6‐induced P‐Stat3 and its related EMT and ECM‐related biomarkers, and upregulate the expression of epithelial marker E‐cadherin (Figure 6A,B), to inhibit the metastatic potential of cervical cancer cells and play an antitumor role.